基于院前因素的院内心搏骤停预后模型:系统综述、Meta分析与批判性评价
本系统综述遵循CHARMS和PRISMA指南,检索Medline、Embase、Web of Science至2021年10月,纳入33项研究(16项模型开发、5项模型更新、12项模型验证),用PROBAST清单进行批判性评价,并对经外部验证模型的AUROC进行随机效应Meta分析。最常见的院前因素包括年龄、功能状态、(转移性)恶性肿瘤、心脏病、脑血管事件、呼吸/肾/肝功能不全、低血压和脓毒症;仅6个开发模型在外部人群中独立验证。GO-FAR评分表现最佳,汇总AUROC为0.78(95%CI 0.69-0.85),PAM为0.59(95%CI 0.50-0.68),PAR为0.62(95%CI 0.49-0.74)。结论认为多数模型存在中等偏倚风险且未经外部验证,GO-FAR评分表现最可接受,未来研究应聚焦更新现有模型以用于临床场景,特别是复苏前咨询。
要点
- GO-FAR评分在经外部验证的院内心搏骤停院前预后模型中表现最佳,汇总AUROC为0.78(95%CI 0.69-0.85)。
- PAM汇总AUROC为0.59(95%CI 0.50-0.68),PAR为0.62(95%CI 0.49-0.74),均低于GO-FAR。
- 33项纳入研究中仅6个开发模型在外部人群中独立验证,多数模型存在中等偏倚风险且未经外部验证。
- 最常用的院前预测因素包括年龄、功能状态、(转移性)恶性肿瘤、心脏病、脑血管事件、呼吸/肾/肝功能不全、低血压和脓毒症。
- 作者认为未来研究应聚焦更新现有模型以用于临床场景,特别是复苏前咨询。
适用人群与场景
- 纳入标准:开发、更新或验证使用院前因素预测院内心搏骤停尝试复苏后任何潜在临床结局的预测模型的研究。
研究设计与关键结果
- 系统综述遵循CHARMS和PRISMA指南,检索Medline、Embase、Web of Science至2021年10月,初筛2678篇文献,最终纳入33项研究:16项模型开发研究、5项模型更新研究、12项模型验证研究。
- 仅6个开发模型在外部人群中独立验证。
- GO-FAR评分汇总AUROC为0.78(95%CI 0.69-0.85),PAM为0.59(95%CI 0.50-0.68),PAR为0.62(95%CI 0.49-0.74)。
证据类型、等级与局限
- 证据类型:系统综述与Meta分析,按PROBAST清单进行批判性评价,对经外部验证模型的AUROC进行随机效应Meta分析。
- 多数模型存在中等偏倚风险且未经外部验证。
- 系统综述注册号PROSPERO CRD42021269235,注册日期2021年7月21日。
对床旁实践的改变
- 作者认为GO-FAR评分表现最可接受,但多数模型存在中等偏倚风险且未经外部验证。
- 作者认为未来研究应聚焦更新现有模型以用于临床场景,特别是复苏前咨询。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Several prediction models of survival after in-hospital cardiac arrest (IHCA) have been published, but no overview of model performance and external validation exists. We performed a systematic review of the available prognostic models for outcome prediction of attempted resuscitation for IHCA using pre-arrest factors to enhance clinical decision-making through improved outcome prediction.
METHODS: This systematic review followed the CHARMS and PRISMA guidelines. Medline, Embase, Web of Science were searched up to October 2021. Studies developing, updating or validating a prediction model with pre-arrest factors for any potential clinical outcome of attempted resuscitation for IHCA were included. Studies were appraised critically according to the PROBAST checklist. A random-effects meta-analysis was performed to pool AUROC values of externally validated models.
RESULTS: Out of 2678 initial articles screened, 33 studies were included in this systematic review: 16 model development studies, 5 model updating studies and 12 model validation studies. The most frequently included pre-arrest factors included age, functional status, (metastatic) malignancy, heart disease, cerebrovascular events, respiratory, renal or hepatic insufficiency, hypotension and sepsis. Only six of the developed models have been independently validated in external populations. The GO-FAR score showed the best performance with a pooled AUROC of 0.78 (95% CI 0.69-0.85), versus 0.59 (95%CI 0.50-0.68) for the PAM and 0.62 (95% CI 0.49-0.74) for the PAR.
CONCLUSIONS: Several prognostic models for clinical outcome after attempted resuscitation for IHCA have been published. Most have a moderate risk of bias and have not been validated externally. The GO-FAR score showed the most acceptable performance. Future research should focus on updating existing models for use in clinical settings, specifically pre-arrest counselling. Systematic review registration PROSPERO CRD42021269235. Registered 21 July 2021.
参考来源
- Grandbois van Ravenhorst C, Schluep M, Endeman H, et al. Prognostic models for outcome prediction following in-hospital cardiac arrest using pre-arrest factors: a systematic review, meta-analysis and critical appraisal. Crit Care. 2023. PMID: 36670450. doi:10.1186/s13054-023-04306-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。